These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9298756)

  • 1. Structure-activity relationship of the affinity of 5-substituted uracil nucleoside analogues for varicella-zoster virus thymidine kinase and their activity against varicella-zoster virus.
    Ashida N; Watanabe Y; Miura S; Kano F; Sakata S; Yamaguchi T; Suzutani T; Machida H
    Antiviral Res; 1997 Aug; 35(3):167-75. PubMed ID: 9298756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
    Yokota T; Konno K; Mori S; Shigeta S; Kumagai M; Watanabe Y; Machida H
    Mol Pharmacol; 1989 Aug; 36(2):312-6. PubMed ID: 2549386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral potencies of BV-araU and related nucleoside analogues against varicella-zoster virus in different cell lines.
    Machida H; Ijichi K; Ohta A; Honda M; Niimura M
    Microbiol Immunol; 1990; 34(11):959-65. PubMed ID: 1965323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of varicella-zoster virus by a novel class of highly specific anti-VZV bicyclic pyrimidine nucleosides.
    Balzarini J; McGuigan C
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):287-95. PubMed ID: 12084470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activity of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against thymidine kinase negative strains of varicella-zoster virus.
    Kawai H; Yoshida I; Suzutani T
    Microbiol Immunol; 1993; 37(11):877-82. PubMed ID: 8295566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the selectivity of anti-varicella-zoster virus nucleoside analogues.
    Machida H; Nishitani M; Watanabe Y; Yoshimura Y; Kano F; Sakata S
    Microbiol Immunol; 1995; 39(3):201-6. PubMed ID: 7603364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2'-O-Acyl/alkyl-substituted arabinosyl nucleosides as inhibitors of human mitochondrial thymidine kinase.
    Balzarinia J; Degrève B; Zhu C; Durini E; Porcu L; De Clercq E; Karlsson A; Manfredini S
    Biochem Pharmacol; 2001 Mar; 61(6):727-32. PubMed ID: 11266658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific recognition of the bicyclic pyrimidine nucleoside analogs, a new class of highly potent and selective inhibitors of varicella-zoster virus (VZV), by the VZV-encoded thymidine kinase.
    Sienaert R; Naesens L; Brancale A; De Clercq E; McGuigan C; Balzarini J
    Mol Pharmacol; 2002 Feb; 61(2):249-54. PubMed ID: 11809847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes.
    Koyano S; Suzutani T; Yoshida I; Azuma M
    Antimicrob Agents Chemother; 1996 Apr; 40(4):920-3. PubMed ID: 8849252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-alkynyl analogs of arabinouridine and 2'-deoxyuridine: cytostatic activity against herpes simplex virus and varicella-zoster thymidine kinase gene-transfected cells.
    Cristofoli WA; Wiebe LI; De Clercq E; Andrei G; Snoeck R; Balzarini J; Knaus EE
    J Med Chem; 2007 Jun; 50(12):2851-7. PubMed ID: 17518459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing the sensitivities of noncognate inhibitors to varicella zoster virus thymidine kinase: implications for postherpetic neuralgia therapy with existing agents.
    Yang L; Mo X; Yang H; Dai H; Tan F
    J Mol Model; 2014 Jul; 20(7):2321. PubMed ID: 24961898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative inhibition of DNA polymerases from varicella zoster virus (TK+ and TK-) strains by (E)-5-(2-bromovinyl)-2'-deoxyuridine 5'-triphosphate.
    Yokota T; Konno K; Shigeta S; De Clercq E
    Mol Pharmacol; 1984 Sep; 26(2):376-80. PubMed ID: 6090888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bicyclic nucleoside inhibitors of varicella-zoster virus modified on the sugar moiety: 3' and 5' derivatives.
    Luoni GM; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
    Antivir Chem Chemother; 2004 Nov; 15(6):333-41. PubMed ID: 15646647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of varicella-zoster virus to thymidine analogues.
    Machida H
    Biken J; 1986 Mar; 29(1):1-6. PubMed ID: 3022708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiherpesvirus activities of 5-alkyl-2-thiopyrimidine nucleoside analogues.
    Shigeta S; Mori S; Watanabe F; Takahashi K; Nagata T; Koike N; Wakayama T; Saneyoshi M
    Antivir Chem Chemother; 2002 Mar; 13(2):67-82. PubMed ID: 12238531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of DNA synthesis in varicella-zoster virus-infected cells by BV-araU.
    Machida H; Watanabe Y
    Microbiol Immunol; 1991; 35(2):139-45. PubMed ID: 1653394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varicella-zoster virus thymidine kinase gene and antiherpetic pyrimidine nucleoside analogues in a combined gene/chemotherapy treatment for cancer.
    Degrève B; Andrei G; Izquierdo M; Piette J; Morin K; Knaus EE; Wiebe LI; Basrah I; Walker RT; De Clercq E; Balzarini J
    Gene Ther; 1997 Oct; 4(10):1107-14. PubMed ID: 9415318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activities of 4-O-(difluoromethyl)-5-substituted-uracil nucleoside analogues.
    Reefschläger J; Pein CD; Cech D
    J Med Chem; 1988 Feb; 31(2):393-7. PubMed ID: 2828623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strains of varicella-zoster virus resistant to 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
    Sakuma T
    Antimicrob Agents Chemother; 1984 Jun; 25(6):742-6. PubMed ID: 6331298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase.
    Grignet-Debrus C; Cool V; Baudson N; Degrève B; Balzarini J; De Leval L; Debrus S; Velu T; Calberg-Bacq CM
    Cancer Gene Ther; 2000 Feb; 7(2):215-23. PubMed ID: 10770629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.